| The role of microRNA-binding site polymorphisms in DNA repair genes as risk factors for bladder cancer and breast cancer and their impact on radiotherapy outcomes. Teo M.T., Landi D., Taylor C.F., Elliott F., Vaslin L., Cox D.G., Hall J., Landi S., Bishop D.T., Kiltie A.E.
Carcinogenesis 33:581-586(2012) · Mapped (6) |
| In vitro functional effects of XPC gene rare variants from bladder cancer patients. Qiao B., Ansari A.H., Scott G.B., Sak S.C., Chambers P.A., Elliott F., Teo M.T., Bentley J., Churchman M., Hall J. et al.
Carcinogenesis 32:516-521(2011) · Mapped (12) |
| MRE11 expression is predictive of cause-specific survival following radical radiotherapy for muscle-invasive bladder cancer. Choudhury A., Nelson L.D., Teo M.T., Chilka S., Bhattarai S., Johnston C.F., Elliott F., Lowery J., Taylor C.F., Churchman M. et al.
Cancer Res. 70:7017-7026(2010) · Mapped (4) |
| AKT1 mutations in bladder cancer: identification of a novel oncogenic mutation that can co-operate with E17K. Askham J.M., Platt F., Chambers P.A., Snowden H., Taylor C.F., Knowles M.A.
Oncogene 29:150-155(2010) · Mapped (5) |
| Spectrum of phosphatidylinositol 3-kinase pathway gene alterations in bladder cancer. Platt F.M., Hurst C.D., Taylor C.F., Gregory W.M., Harnden P., Knowles M.A.
Clin. Cancer Res. 15:6008-6017(2009) · Mapped (7) |
| Genomic deletions in MSH2 or MLH1 are a frequent cause of hereditary non-polyposis colorectal cancer: identification of novel and recurrent deletions by MLPA. Taylor C.F., Charlton R.S., Burn J., Sheridan E., Taylor G.R.
Hum. Mutat. 22:428-433(2003) · UniProtKB (2) · Mapped (40) |
| Expression of a homeo domain protein in noncontact-inhibited cultured cells and postmitotic neurons. Odenwald W.F., Taylor C.F., Palmer-Hill F.J., Friedrich V. Jr., Tani M., Lazzarini R.A.
Genes Dev. 1:482-496(1987) · UniProtKB (1) · Mapped (9) |
